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Abstract: Patient-centered home care is a new model of assistance, which may be integrated 
with more traditional hospital-centered care especially in selected groups of informed and trained 
patients. Patient-centered care is based on patients’ needs rather than on prognosis, and takes 
into account the emotional and psychosocial aspects of the disease. This model may be applied 
to elderly patients, who present comorbid diseases, but it also fits with the needs of younger fit 
patients. A specialized multidisciplinary team coordinated by experienced medical oncologists 
and including pharmacists, psychologists, nurses, and social assistance providers should carry 
out home care. Other professional figures may be required depending on patients’ needs. Every 
effort should be made to achieve optimal coordination between the health professionals and the 
reference hospital and to employ shared evidence-based guidelines, which in turn guarantee 
safety and efficacy. Comprehensive care has to be easily accessible and requires a high level 
of education and knowledge of the disease for both the patients and their caregivers. Patient-
centered home care represents an important tool to improve quality of life and help cancer 
patients while also being cost effective.
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Introduction
In the Western world cancer is the most common cause of premature death and 
  disability, with very important social and economic consequences that at present 
are not precisely measured, and therefore often ignored. National health systems are 
faced with an increasing incidence and prevalence of cancer as the whole population 
lives longer.1 In practical terms, oncology organizations have to support an   increasing 
number of patients requiring more therapeutic interventions, long lasting care, and 
longer follow-up time.2 Consequently, there is an increasing need for resources to 
manage the long-term survivors, and provide ongoing patient education and better 
psychosocial support. To deal with this problem, health providers need to find a more 
flexible model of cancer care in order to meet patient needs.
In 2005 the USA Institute of Medicine identified six major phases in the cancer 
care continuum: prevention, early detection, diagnosis, treatment, survivorship, and 
end-of-life care.3 According to this schema, improvement of care and quality of life as 
well as the development of new models of care were reported as major objectives.
Quality of care
Patient-centered care is considered a pivotal aspect of high-quality health care.4 As shown 
in Figure 1, high-quality health care includes all of the followings aims: (a)   effectiveness, Therapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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i.e. the use of evidence-based medicine; (b) safety, including 
avoidance of preventable errors; (c) efficiency, in order to 
reduce waste as much as possible; (d) timeliness, in order to 
avoid unnecessary delays; and (e) equity, regardless of sociode-
mographic characteristics.4 Patient-centered care is “respectful 
of and responsive to individual patient preferences, needs and 
values.”5 These aims may well be applied also in oncology in 
which patient-health provider communication and relationships 
are of paramount importance. Coordination of care represents 
another fundamental pillar of high-quality health care due to the 
multidisciplinary approach to cancer patients. The concept of 
patient-centered assistance is further strengthened by the contin-
uously increasing personalization of antineoplastic treatments 
as a positive consequence of biological and medical knowledge 
achieved in the last decade.6 Patient-centered research has also 
been advocated for participation in   prospectively randomized 
clinical trials.7
The aims of patient-centered care fit very well in a cancer 
management home program, which represents a new model 
of cancer care which may be integrated with more traditional 
models of assistance.8 Cancer patient-centered home care 
(CPCHC) programs may include the active assistance of 
patients treated with oral or even intravenous agents, both 
chemotherapeutic and biologic drugs, outside of the hospital 
clinic. In a strict sense, home chemotherapy refers to the full 
home administration of treatment, even if infusion chemo-
therapy may be started at the hospital and continued – as 
often happens today – at home without supervision.
At a first glance, the CPCHC approach is obviously con-
sidered applicable to unfit or elderly patients but in reality, it 
may also extend to fit patients. Fit patients usually have less 
hospital needs and better tolerance to oncological treatments. 
Moreover it should be considered that emotional and psycho-
social aspects play a pivotal role since cancer patients often 
feel more comfortable and secure being cared for at home. 
Many patients want to stay at home so that they will not be 
separated from family, friends, and familiar surroundings.
Principles of cancer patient-
centered home care
CPCHC is considered as the future of primary care practice 
that will be part of the US health care system change into 
a more accessible, effective, efficient, safe, and economi-
cal sustainable system. In accordance with similar medical 
  systems, this new model of assistance must incorporate sev-
eral principles of care shown in Table 1.9,10 The guidelines 
of the Association of Community Cancer Centers homecare 
program state that “the home cancer care staff must be 
capable of providing appropriate and competent care for 
cancer patients and their families at any stage of the disease”. 
Therefore CPCHC must be run by a highly specialized health 
care team coordinated by experienced oncologists and must 
work in cooperation with affiliated comprehensive cancer 
centers and other health care providers in order to guarantee 
an adequate and coordinated continuum of care and an ongo-
ing relationship between patients and physicians.
The progression of any cancer patient through the cancer 
care continuum is not straightforward and has in fact been 
described as a labyrinth.11 The key issues at the basis of any 
home anticancer treatment service are outlined in Table 2. 
The coordinating oncologist and the whole caregiver team 
have the responsibility of guiding and supporting patients 
therefore enabling and empowering patients to live with 
cancer as a chronic disease.11 Care should be directed to the 
whole person’s needs, which may vary from preventive to 
end of life or from acute to chronic care. In accomplishing 
these aims, the involvement of family caregivers is essen-
tial for optimal management of cancer patients in ensuring 
treatment adherence and persistence, continuity of care, and 
social support, particularly in the most critical phases such as 
communication of diagnosis or at the end of life.12 In many 
cases caregivers intervene under the pressure of sudden 
and extreme circumstances, without adequate   education, 
  knowledge of the disease or support from the health care 
Table  1  Principles  of  cancer  patient-centered  home  care 
(CPCHC)
• Oncologist-directed health care team
• Ongoing patient-physician relationships
• Coordinated and comprehensive care
• evidence-based medicine (quality and safety)
• Patient and family education and empowerment
• enhanced access
• Payment issues
High quality care
Equity
Effectiveness
Efficiency Timeliness
Safety
Coordination
Patient centered
care
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system. Safety and quality of therapies and care should 
be met as much as possible by using shared and accepted 
evidence-based guidelines and the use of clinical decision 
support tools, accurate information, and patient information.13 
In this setting, trained nurses and pharmacists play a pivotal 
role along with the physician, social support givers, and fam-
ily. Access to oncological care should be enhanced through 
various systems such as open scheduling, extended contact 
time, and improved methods of communication. Therefore 
accurate coordination between all segments of this continuum 
of care and the patient’s community plays a pivotal role.
Measures of patient-centered care
To  date  no  widely  accepted  conceptual  model  of 
  patient-centered care exists.14 Figure 2 shows a possible 
framework including four dimensions: disease experience 
  (patient-as-person); whole person (bio-psychosocial 
  perspective); common ground (sharing power and respon-
sibility); and patient–physician relationship (therapeutic 
alliance). Several approaches have been employed for 
creating instruments to measure patient-centered care. The 
most widely employed approaches are direct observation by 
the heath care provider in the form of a structured objective 
checklist; physician reports; and patient self-assessment 
through the use of questionnaires, the latter being the most 
precise in predicting outcomes.15
Clinical evidence
The issue of home therapy in oncology care is not new. In 
1989 McCorkle et al carried out a randomized clinical trial 
to determine the effects of home nursing care versus usual 
office care for 166 patients with progressive lung cancer.16 
Although there were no differences in pain, mood distur-
bance, and concerns, significant differences in symptom 
distress, enforced social dependency, and health perceptions 
were reported. These results suggested that home nursing care 
assists patients with forestalling distress from symptoms and 
maintaining their independence longer in comparison to no 
home nursing care.
Despite widespread attention and endorsement by health 
care agencies, limited research exists evaluating principles of 
cancer patient-centered home care or testing the effectiveness 
of this model in community practice. There is insufficient 
evidence about the effectiveness, in terms of clinical out-
comes (survival, objective response), of home chemotherapy 
compared to hospital administration.17 More sound evidence 
exists on safety, although patients must be carefully selected 
and trained. Home delivery of anticancer agents is feasible 
for selected categories of patients such as those receiving 
oral treatments, zoledronic acid, low-intensity intravenous 
chemotherapy (ie, gemcitabine or vinorelbine) or biologic 
agents (ie, herceptin), while patients receiving intensive 
treatments are not suitable for home care. Table 3 shows the 
advantages of a home therapy care unit for both patients and 
health-providers.
In the last decade, the use of antineoplastic agents has 
increased dramatically, as the number of cancer patients has 
risen and developments in technology have expanded the 
groups suitable for treatments, especially those involving 
long infusions or requiring oral therapy and/or less complex 
chemotherapy regimens.18 In the UK and the US, the excessive 
burden on some chemotherapy units has led to the develop-
ment of an innovative concept of care model which would 
allow less complex cancer treatments to be delivered at home 
Table 2 Key issues for a home anticancer treatment service
• High-quality integrated services by a trained multidisciplinary team
• Accurate selection of patients and caregivers, who need to be trained
• Keep staff training up to date
• Measure outcomes for service evaluation
• Guide the team service to build clinical and patient confidence
•   Adherence to medical care and safety procedures and use  
of evidence-based protocols
• Cooperation between health providers from various disciplines
• Strong communication networks in order to avoid care fragmentation
• Coordination between hospital chemotherapy service and home setting
• Ability of the service to flexibly respond to cancer patients’ needs
• engage the expertise and experience of colleagues
•   Survey patients for feedback on their choice and experience of  
home healthcare
Disease
experience
Patient as
a person
Whole person
Psychosocial
perspective
Common
ground
Sharing
responsibilities
Patient-
oncologist
relationship
Therapeutic
alliance
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outside of the acute hospital setting.19 For instance the Christie 
NHS Foundation Trust in the UK has rapidly implemented the 
home delivery of trastuzumab to early-stage HER2-positive 
breast cancer patients after the first three hospital administra-
tions in the absence of significant side effects. All treatment 
is carried out under the direction of the patient’s oncologist, 
who retains ultimate responsibility for the patient’s care and 
with whom close contact is maintained at all times. Another 
study carried out in Ireland including 274 patients, of whom 
39 were treated at home with 5-fluorouracil infusion-based 
chemotherapy, reported high levels of patient satisfaction 
(80%) with the services received at home and the level of 
information received.20 More than 90% of patients felt home 
treatment was less distressing than hospital admission. Fear 
of in-hospital acquired infection was reported by 50% of 
patients, while less than 10% reported that they missed the 
company of patients in a similar position.
The Health Technology Assessment Agency of Canada 
analyzed home cancer chemotherapy in terms of patient 
benefit, safety, costs, organizational issues, and delivery 
implications.21 Home oral and intravenous cancer treatment is 
feasible for some patients and can be delivered safely if indi-
viduals and their familiar caregivers are carefully selected and 
trained. Patient eligibility criteria include learning capability, 
home environment, and geographic accessibility. The latter 
issue raises problems since home therapy may be quite dif-
ficult in rural areas. Although improvements in patient qual-
ity of life at home have not been well documented, patient 
preference/satisfaction with home therapy is evident.
An efficient CPHCP must work in a strategic   partnership 
with the reference oncology hospital. In a large study   carried 
out in the US, 756 patients with advanced stage disease, 
of which 75% were oncology patients, were included in a 
patient-centered model including home visits and telephone 
calls.22 This program resulted in a reduction of hospital admis-
sions (38%), emergency room visits (30%), and number 
of diagnoses of side effects, such as nausea, anemia, and 
dehydration. Patients’ satisfaction rate was high (92%), with 
an increase in the use of hospice and home care of 62% and 
30%, respectively.
A randomized crossover trial was carried out at the Peter 
MacCallum Cancer Institute in Melbourne, Australia, to 
determine patients’ preferences and cost differences between 
home-based and hospital-based chemotherapy.23 Although 
only 20 patients were enrolled, home-based chemotherapy 
was the preferred option by all patients. There were no 
significant complications associated with administration 
of chemotherapy in the home and no negative reports by 
patients themselves.
The application of approved treatment guidelines is 
extremely useful in improving cancer care as shown by a 
report from a home care program in the US.24 A standardized 
approach to dehydration prevention education and manage-
ment resulted in fewer patients seeking emergency aid and 
inpatient care for dehydration, while standardized manage-
ment of outpatient diarrhea cut the number of admissions for 
treatment of Clostridium difficile enteritis by more than 50%. 
Likewise, standardized prevention of delayed nausea and 
vomiting due to chemotherapy dramatically decreased the 
practice-wide use of oral 5-hydroxytryptamine 3   inhibitors. 
These actions ultimately minimized irrelevant activities that 
steal time from the oncologist’s day. A steady decrease in 
the number and rate of emergency department referrals for 
chemotherapy patients has been recorded if patient-centered 
care is applied. Overall, hospital admissions for cancer 
patients fell by 16% between 2008 and 2009 and fell by 
another 10% in 2010.24
Oral therapies
In the last decade, the use of oral anticancer agents for the 
treatment of various types of cancer has been constantly 
increasing.25,26 Of all the cancer therapies under clinical 
development, 20%–25% are expected to be oral. Currently 
in the US and Europe, more than 40 oral agents have been 
approved for the treatment of cancer. The intravenous-to-oral 
switch and the development of oral anticancer therapies for 
long-term daily use will most likely continue to evolve. The 
issue of oral cancer therapy is particularly important in a 
model of patient-centered home care. Oral treatments de 
Table 3 Advantages of a home therapy care unit
Patients’ advantages:
 •  improved symptom and medication management
 •  improved medication adherence
 •    Optimized treatment outcomes through minimized or avoided  
treatment delays
 •  improved quality of physical and spiritual aspects of life
 •  enhanced psychosocial and caregiver support
 •  Reduced unnecessary emergency visits and hospitalizations
 •  Reduced length of hospital stay
 •  Reduction in waiting times
Health providers’ advantages:
 •  Accurate monitoring of patient at home
 •  Provision of concise, accurate clinical updates
 •  Reinforcement of patient teaching done at office
 •  Reduction of calls to the office
 •  Reduction of malpractice claims
 •  improvements in physician satisfactionTherapeutics and Clinical Risk Management 2011:7 submit your manuscript | www.dovepress.com
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facto represent a home therapy since most patients take pills 
at their houses and manage their treatment directly or with 
their familiar caregivers.25
Economic issues
Costs and convenience of delivering cancer treatments at 
home versus hospital services were analyzed in a study of 
82 patients who received home cancer treatment for at least 
2 weeks under the coordination of a public cancer center 
in Lyon, France.27 The hypothetical costs of hospital stay 
were reconstructed for each individual receiving home care 
according to the type of cancer care required: chemotherapy, 
palliative care, and other treatments. Home cancer treatments 
were less costly than traditional inpatient hospital care for 
the palliative care and other treatment groups, while no 
  significant cost difference was found for the chemotherapy 
group. However, because this study evaluated costs from the 
perspective of the public payer, costs borne by the individual 
or family were not considered. Therefore the cost effective-
ness of home versus hospital cancer programs from a societal 
perspective, which would include costs borne by the indi-
vidual and family receiving care, should also be analyzed.
The Irish experience showed that home care cut costs 
by two-thirds compared to hospital care.20 If savings associ-
ated with transport and increased risk of hospital acquired 
infection were taken into account, the study suggested that 
home chemotherapy would appear even more cost advanta-
geous and provide even better economic advantage for the 
tax payer. In a US study, cost analysis also showed a reduc-
tion in expenses as compared to patients not enrolled in the 
program.22 On the other hand a Canadian study reported that 
home chemotherapy was less costly than inpatient treatment 
in a hospital, but findings were mixed when home therapy 
was used as a substitute for outpatient therapy.21 In the 
Australian experience, home-based treatment resulted in an 
increased cost compared with hospital-based treatment, but 
it was associated with several advantages such as elimina-
tion of travel, reduction in treatment-associated anxiety, and 
reduction in the burden on health carers and family, and the 
ability to continue other work.23 Major cost savings (56%) 
were reported in a retrospective review carried out in the UK 
in administering home chemotherapy over a 1-year period 
compared to in-hospital treatment.28
Conclusion
Today, improvement in the quality of care for cancer patients 
through a patient-centered approach is seen as a strategic 
priority. Patient-centered care is based on patients’ needs 
rather than on prognosis. The delivery of oncology care at 
home is increasingly viewed as a way of improving quality 
of care and as a cost-effective alternative to inpatient hospital 
treatment for selected groups of patients. In fact the primary 
setting for the delivery of care to patients with cancer has 
shifted from the hospital to the home as a result of increased 
use of outpatient services for cancer treatment, the advent of 
oral therapies, shortened hospital visits, longer survival, and 
the trend for caregivers to accommodate patients’ desire to 
be cared for at home for as long as possible.
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